Alpha-Internexin Expression Predicts Outcome in Anaplastic Oligodendroglial Tumors and May Positively Impact the Efficacy of Chemotherapy

K. Mokhtari; F. Ducray; J.M. Kros; T Gorlia; A. Idbaih; M. Taphoorn; P. Wesseling; K. Hoang-Xuan; M. Van den Bent; M. Sanson

doi:10.1002/cncr.25827

Alpha-Internexin Expression Predicts Outcome in Anaplastic Oligodendroglial Tumors and May Positively Impact the Efficacy of Chemotherapy

K. Mokhtari
, F. Ducray
, J.M. Kros
, T Gorlia
, A. Idbaih
, M. Taphoorn
, P. Wesseling
, K. Hoang-Xuan
, M. Van den Bent
, M. Sanson

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	3014-3026
Journal	Cancer
Volume	117
Issue number	13
DOIs	https://doi.org/10.1002/cncr.25827
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/cncr.25827

Cite this

@article{b22eceefc3fa41f58b4cdd7f242b3dbc,

title = "Alpha-Internexin Expression Predicts Outcome in Anaplastic Oligodendroglial Tumors and May Positively Impact the Efficacy of Chemotherapy",

author = "K. Mokhtari and F. Ducray and J.M. Kros and T Gorlia and A. Idbaih and M. Taphoorn and P. Wesseling and K. Hoang-Xuan and \{Van den Bent\}, M. and M. Sanson",

year = "2011",

doi = "10.1002/cncr.25827",

language = "Undefined/Unknown",

volume = "117",

pages = "3014--3026",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "13",

}

TY - JOUR

T1 - Alpha-Internexin Expression Predicts Outcome in Anaplastic Oligodendroglial Tumors and May Positively Impact the Efficacy of Chemotherapy

AU - Mokhtari, K.

AU - Ducray, F.

AU - Kros, J.M.

AU - Gorlia, T

AU - Idbaih, A.

AU - Taphoorn, M.

AU - Wesseling, P.

AU - Hoang-Xuan, K.

AU - Van den Bent, M.

AU - Sanson, M.

PY - 2011

Y1 - 2011

U2 - 10.1002/cncr.25827

DO - 10.1002/cncr.25827

M3 - Article

C2 - 21246521

SN - 0008-543X

VL - 117

SP - 3014

EP - 3026

JO - Cancer

JF - Cancer

IS - 13

ER -